Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

A Bonaventura, A Vecchié, L Dagna… - Nature Reviews …, 2021 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …

[HTML][HTML] Neutrophils and COVID-19: The road so far

LHA Cavalcante-Silva, DCM Carvalho… - International …, 2021 - Elsevier
The SARS-Cov2 infection triggers a multisystem inflammatory disorder, knowing as COVID-
19, a pandemic disease. This disease is characterized by acute respiratory distress …

[HTML][HTML] Neutrophil elastase: From mechanisms to therapeutic potential

W Zeng, Y Song, R Wang, R He, T Wang - Journal of Pharmaceutical …, 2023 - Elsevier
Neutrophil elastase (NE), a major protease in the primary granules of neutrophils, is
involved in microbicidal activity. NE is an important factor promoting inflammation, has …

D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity

J Hu, CL He, QZ Gao, GJ Zhang, XX Cao, QX Long… - BioRxiv, 2020 - biorxiv.org
Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). The spike (S) protein that mediates SARS-CoV-2 …

Targeting neutrophils to treat acute respiratory distress syndrome in coronavirus disease

CC Chiang, M Korinek, WJ Cheng… - Frontiers in …, 2020 - frontiersin.org
This review describes targeting neutrophils as a potential therapeutic strategy for acute
respiratory distress syndrome (ARDS) associated with coronavirus disease 2019 (COVID …

[HTML][HTML] Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID‐19‐associated thrombopathy

A Caillon, A Trimaille, J Favre, L Jesel, O Morel… - Journal of Thrombosis …, 2022 - Elsevier
The COVID‐19 pandemic extended all around the world causing millions of deaths. In
addition to acute respiratory distress syndrome, many patients with severe COVID‐19 …

Neutrophil Elastase inhibitor (Sivelestat), may be a promising therapeutic option for Management of Acute Lung Injury/acute respiratory distress syndrome or …

A Sahebnasagh, F Saghafi, M Safdari… - Authorea …, 2020 - advance.sagepub.com
This article summarizes the effects of sivelestat on ALI/ARDS or ARDS with coagulopathy,
both of which are frequently seen in patients with COVID-19. The emergence of the novel …

The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update

SA Jasim, RS Mahdi, DO Bokov… - Journal of Medical …, 2022 - Wiley Online Library
The precise interaction between the immune system and severe acute respiratory syndrome
coronavirus 2 (SARS‑CoV‑2) is critical in deciphering the pathogenesis of coronavirus …

Peptide human neutrophil elastase inhibitors from natural sources: an overview

L Marinaccio, A Stefanucci, G Scioli… - International Journal of …, 2022 - mdpi.com
Elastases are a broad group of enzymes involved in the lysis of elastin, the main component
of elastic fibres. They are produced and released in the human body, mainly by neutrophils …

Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19

M Peyneau, V Granger, PH Wicky, D Khelifi-Touhami… - Scientific reports, 2022 - nature.com
COVID-19 can cause acute respiratory distress syndrome, leading to death in many
individuals. Evidence of a deleterious role of the innate immune system is accumulating, but …